Year: 2023

Rising demand for medical robots owing to their performance is one of the major factors driving medical robotic systems market revenue growth. Vancouver, Dec. 07, 2023 (GLOBE NEWSWIRE) — The global medical robotic systems market size was USD 21.20 Billion in 2022 and is expected to register a revenue CAGR of 16.1% during the forecast period, according to the latest analysis by Emergen Research. Rising demand for medical robots owing to their performance is a major factor driving the market revenue growth. Medical robots are designed to aid surgeons during operations or procedures on patients who require assistance in recovering from an illness or accident. Medical robots have reduced the danger of infection in hospitals by reducing necessity for human touch with patients. Robotic systems enable minimally invasive procedures, such...

Rising demand for ammonium nitrate fuel oil is a major driving factor driving Ammonium Nitrate market revenue growth. Vancouver, Dec. 07, 2023 (GLOBE NEWSWIRE) — The global ammonium nitrate market size was USD 15.5 Billion in 2023 and is expected to register a revenue CAGR of 3.4 % during the forecast period. A key driver of this growth is the rising demand for ammonium nitrate fuel oil, particularly in the mining industry, as it plays a crucial role in blasting rocks and accelerating the burning of combustible materials. The International Energy Agency reports a surge in mining projects globally, with around 4,700 projects valued at USD 318 billion planned for construction in 2023. This robust demand for minerals, essential for clean energy production, underscores the pivotal role ammonium nitrate plays in the sector. Small-scale...

Rising Research & Development (R&D) activities to grow heparin with enhanced therapeutic potential and minimum side effects are is key factors driving heparin market revenue growth. Vancouver, Dec. 07, 2023 (GLOBE NEWSWIRE) — The global heparin market size was USD 5.58 Billion in 2022 and is expected to register a rapid revenue CAGR of 5.5% during the forecast period. Key factors propelling market growth include heightened government support for healthcare infrastructure, a surge in Research & Development (R&D) activities to enhance heparin’s therapeutic potential, and minimal side effects. Heparin, a glycosaminoglycan renowned as Unfractionated Heparin (UFH), acts as a crucial anticoagulant (blood thinner) in medical applications. The Centers for Disease Control and Prevention (CDC) reports that around...

Rising demand for energy-efficient and sustainable construction materials and light-weighting initiatives in the automotive industry and increasing utilization in transportation applications and preference for corrosion-resistant materials are key factors driving Sheet Molding Compound market revenue Vancouver, Dec. 07, 2023 (GLOBE NEWSWIRE) — The global Sheet Molding Compound (SMC) market size was USD 3.51 Billion in 2022 and is expected to register a rapid revenue CAGR of 5.8% during the forecast period. The escalating demand for energy-efficient and sustainable construction materials, coupled with initiatives in the automotive industry for light weighting, is a driving force behind this growth. SMC, a versatile composite material, is gaining traction across diverse industries, including automotive, aerospace, electrical, construction,...

Growing prevalence of cancer and cardiac diseases among people and technological advancements are creating a high demand for medical imaging, thus is expected to drive Medical Imaging Market revenue growth Vancouver, Dec. 07, 2023 (GLOBE NEWSWIRE) — The global medical imaging market, valued at USD 52.03 Billion in 2032, is set to experience substantial growth, with a projected revenue Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period. Key drivers include the increasing prevalence of chronic diseases, particularly cancer and cardiac conditions, coupled with notable technological advancements in the field. The surge in chronic diseases globally, particularly among the elderly population, is a primary catalyst for the expanding medical imaging market. The Centers for Disease Control and Prevention (CDC) estimates...

TEL AVIV, Israel, Dec. 07, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today updates regarding the negotiation following the signing of a non-binding letter of intent (“LOI”) with a leading vehicle importer company in Israel (the “Target Company”), on November 22, 2023. According to the new negotiated terms, the Company will acquire 100% of the Target Company and will establish a new wholly-owned Israeli subsidiary, which would in turn merge with and into the Target Company (the “Acquisition”). Following the Acquisition, it is contemplated that SciSparc shareholders will hold approximately...